Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05945433
Other study ID # Momentis2023GYNRegistry
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 28, 2023
Est. completion date June 2026

Study information

Verified date July 2023
Source Momentis Surgical
Contact Sharon H Branch
Phone 9543033777
Email sharon.branch@momentissurgical.com
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

To collect Real-World Data (RWD) on the ongoing safety and effectiveness of the anovo Surgical system in transvaginal gynecological laparoscopic surgical procedures and to obtain information on the impact of the anovo Skills Development Pathway on user behavior and performance (where performance is measured by the learning curve of the surgeons and procedure outcomes).


Description:

Specific Aims: 1. To collect RWD from surgeons with varying experience and expertise on their learning curve and time to achieve competency, and as such assess the success of the Skills Development Pathway. 2. Collect safety information and analyze the causality between type and frequency of adverse events to surgeons' experience. 3. Evaluate the effectiveness of the device while minimizing bias by enrolling "all comers", which will represent the general patient population.


Recruitment information / eligibility

Status Recruiting
Enrollment 300
Est. completion date June 2026
Est. primary completion date June 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group N/A and older
Eligibility All patients receiving gynecological surgical procedure with the anovo Surgical System by their surgeon will be offered to participate in the registry. Inclusion Criteria: - patients must understand and sign the informed consent form, including data privacy authorization, indicating their consent to participate in the registry study. - willing to complete post-operative questionnaire Exclusion Criteria: -none

Study Design


Related Conditions & MeSH terms


Intervention

Device:
anovo™ Surgical System
The anovo Surgical System is an endoscopic instrument control system that is intended to assist in the accurate control of the Instrument ARMS during single site, natural orifice laparoscopic-assisted transvaginal benign surgical procedures.

Locations

Country Name City State
United States AdventHealth Celebration Florida

Sponsors (1)

Lead Sponsor Collaborator
Momentis Surgical

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Surgeon Learning Curve (surgery time against number of operations performed, considering frequency of cases and surgery difficulty) To be reported as a continuous curve (plot per surgeon), and as the mean difference in surgery times between during learning curve and after learning curve stages (stages defined as before the surgeon achieves a steady state surgical time and after the surgeon achieves the steady state) Procedure
Other Surgeon Safety Curve (cumulative UADEs against number of operations performed) Procedure
Other User Skills Development Survey Procedure
Primary Conversion rate to open or laparoscopic approach Procedure
Primary Rate of Unanticipated Adverse Device Effect 8 Weeks Follow Up
Secondary Surgery time (minutes) Procedure
See also
  Status Clinical Trial Phase
Recruiting NCT03675802 - Cervical Preparation in Hysteroscopy N/A
Recruiting NCT05867927 - GENERATE - Next GENERATion of GynEcological Surgery - Robotic Assisted Surgery in Gynecological Indications
Withdrawn NCT05496244 - ROBYN Study - Robotic Assisted Surgery in Gynecological Indications Compared to Conventional Laparoscopy
Completed NCT03123367 - Evaluation of the Nella Women's Care Line N/A
Not yet recruiting NCT05227430 - Standardized Educational Videos of Laparoscopic Gynecological Surgeries N/A
Withdrawn NCT03591289 - Does Depth of Neuromuscular Blockade (NMB) Affect Surgical Conditions in Obese Patients Undergoing Robotic Surgery Phase 4